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ABSTRACT 
Infectious keratitis causes significant, financial burden and is only increasing in frequency with contact lens use. Despite 
this, no retrospective studies, prospective studies, or clinical trials have evaluated the diagnostic validity of clinical 
guidelines in cases of infectious keratitis. Currently, standard of care recommends that corneal samples be obtained for 
staining and culturing in select patients showing evidence of corneal ulceration. Ideally, diagnostic information from 
corneal sampling is thought to help guide therapeutic interventions, prevent disease progression, reduce antibiotic 
resistance, and decrease overall expenditures for the management and treatment of infectious keratitis. However, 
current staining and culturing methods are limited by poor sensitivity in non-bacterial cases (i.e. fungal, viral) and lengthy 
turnaround times, and these methods do not frequently change clinical decision making. Newer fluoroquinolones and 
broad-spectrum antibiotics resolve the vast majority of cases of infectious keratitis, rendering cultures less essential for 
management. We studied the clinical utility of obtaining corneal samples for culturing and staining and the need for 
future research to establish superior diagnostic guidelines for their use in infectious keratitis. 
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INTRODUCTION
A far too common dilemma that cornea specialists and 
general ophthalmologists face is whether to culture 
corneal ulcers. Infectious keratitis is characterized by 
inflammation of the cornea due to microbial infiltration, 
often accompanied by a loss of stroma and disrupted 
epithelium [1, 2]. Patients with infectious keratitis can 
present with rapid-onset pain, blurred vision, 
mucopurulent discharge, and photophobia [3]. Microbial 
infection by bacteria, fungi, viruses, and parasites are all 
causes of infectious keratitis, which can quickly progress 
to ulceration, corneal perforation, endophthalmitis, and 
scarring with subsequent loss of vision [4, 5]. An 
estimated 71,000 cases of ulcerative keratitis occur 
annually in the U.S. [6]; rising incidence has been 
associated with increasing contact lens use [7]. Clinicians 
spend an estimated 250,000 h managing patients with 
keratitis every year, and approximately 175 million USD is 
spent annually treating keratitis and related disorders, 
posing a significant strain on healthcare expenditures [8]. 
With the appearance of broad-spectrum 
fluoroquinolones and fortified antibiotics that clear most 
of these infections, practitioners may question the 
usefulness of collecting corneal scrapings for smears, 
cultures, and antibiotic sensitivity testing. 
Corneal ulcers typically form after a break in the 
epithelium results in stromal infiltration by opportunistic 
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pathogens [5]. Gram-positive bacteria (staphylococcal 
and streptococcal species) are the most common 
bacteria recovered in infectious keratitis. Pseudomonas 
aeruginosa is a frequent Gram-negative cause, especially 
in contact lens overuse [5, 9, 10]. However, regional 
estimates vary [9]. A lack of clinical response may lead a 
clinician to consider less common organisms, such as 
atypical mycobacteria, fungi (i.e., Aspergillus), viruses 
(i.e., herpes simplex virus [HSV]) and Acanthamoeba, as 
causative agents in refractory cases of infectious keratitis 
[10-12]. A significant minority of keratitis is polymicrobial 
in origin, making cultures and smears less useful for 
diagnosis due to the difficulty distinguishing causative 
pathogens from contamination [5, 13].  
METHODS 
To find information on Biological Staining and Culturing 
in Infectious Keratitis, a literature search was performed 
using the following sources: PubMed, Google Scholar, 
Embase, and Scopus. Keywords used in this search 
included infectious keratitis, ulcerative keratitis, bacterial 
keratitis, microbial keratitis, staining, culture, smears, 
antibiotic sensitivity testing, treatment, sensitivity, 
specificity, polymerase chain reaction, fungal keratitis, 
Acanthamoeba, and herpetic keratitis. Articles describing 
infectious keratitis, culturing, and staining were 
systematically reviewed. Reference lists of these articles 
were used to identify additional articles. There were no 
language restrictions. Publications were drawn between 
the dates of 1980-2019. 
 
CURRENT STANDARD OF CARE 
The American Academy of Ophthalmology (AAO) has 
not released a preferred practice pattern specifically 
for infectious keratitis; however, AAO recently 
published the Bacterial Keratitis Preferred Practice 
Pattern, outlining their recommendations for the 
diagnosis and management in suspected cases of 
bacterial keratitis. It advises that smears and cultures 
be collected from ulcers (1) that are large (>2mm) and 
centrally located, (2) with significant stromal melting, 
(3) that are refractory to empiric antibiotic therapy, 
(4) in cases with prior history of corneal surgery, (5) 
with multiple, diffuse, stromal infiltrates, or (6) with 
atypical presentations, suggestive of amoebic, fungal, 
or mycobacterial infection [11]. 
Initial empiric therapies typically start with 
fluoroquinolone eyedrops. Alternatively, a fortified 
aminoglycoside can be used with a cephalosporin or 
vancomycin, depending on initial clinical severity. If 
refractive to empiric therapy and cultures are 
negative, repeat cultures of the ulcer and referral to a 
cornea specialist may be warranted (Table 1) [11]. Yet, 
no retrospective studies, prospective studies, or 
randomized clinical trials to date have evaluated the 
current clinical guidelines for the diagnosis of 
infectious keratitis, leaving much to clinical judgment. 
In a study of 436 ophthalmologists, respondents on 
average culture corneal ulcers in only 35% of cases 
[14]. About 13% of general ophthalmologists willing to 
treat a case of severe ulcerative keratitis would not 
obtain cultures before starting empiric treatment [15]. 
Well-designed prospective studies are needed to 
validate, and possibly improve, current published 
guidelines and unify discrepancies of clinical practice 
within the field of ophthalmology [14-16]. 
 
 
Table 1: Current Diagnostic and Therapeutic Guidelines for Infectious Keratitis 
Abbreviations: KOH: Potassium hydroxide; CFW: Calcofluor white; HSV1: herpes simplex virus type 1; VZV: varicella-zoster virus; CMV: cytomegalovirus; 
N/A: not available; MRC-5: human lung embryonated cells; PHMB: polyhexamethylene biguanide hydrochloride. 
*Specificity not included as these methods are considered the gold standard for the diagnosis of infectious keratitis and theoretically should be 100% in 
the absence of contamination. 
Causative Agent Staining Culture Treatment 
 Type Sensitivity* Type Sensitivity*  
Bacterial 
Gram, Giemsa 
[11] 
57-67% [13, 17, 18] Blood agar, Chocolate agar, 
Thioglycolate broth, Mannitol 
salt agar [11] 
58% [19] Fluoroquinolones  
or aminoglycoside + cephalosporins  
or aminoglycoside + vancomycin 
Viral 
i.HSV1 
 
ii. VZV 
 
iii. CMV 
N/A N/A  
i.Vero cell line [20] 
 
ii. MRC-5 cell line [21] 
 
iii. MRC-5 cell line [22] 
 
i.21% [20] 
 
ii. 46% [21] 
 
i.Acyclovir (oral) + Trifluridine (topical), acyclovir 
(topical), valganciclovir 
ii.Acyclovir (oral), famciclovir (oral), valacyclovir 
(oral), acyclovir (topical) 
iii.Valganciclovir (oral), Valganciclovir (topical) 
Fungal KOH [23, 24] 68-99% [23, 24] Sabouraud dextrose agar [11] 25-59% [24-
27] 
Natamycin, amphotericin, clotrimazole, 
fluconazole, itraconazole, voriconazole 
Acanthamoeba KOH + CFW 
[13] 
84% [13] Buffered charcoal yeast extract, 
Escherichia coli-seeded non-
nutrient agar plates [11] 
33% [28] Chlorhexidine + PHMB  
or chlorhexidine + brolene  
or neomycin 
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Table 2: Advantages and Disadvantages of Culturing Infectious Keratitis 
Advantages of Culturing Infectious Keratitis Disadvantages of Culturing Infectious Keratitis 
Relatively more sensitive in bacterial infections. 
High specificity. 
Guides treatment regimen in refractory cases. 
Prevents treatment failure and/or complications due to wrong initial therapy. 
Shortens exposure to and spending on unnecessary antibiotics. 
Allows for antibiotic sensitivity testing. 
Gives epidemiological data. 
Currently widely available. 
Overall low yield of organisms. 
Less specific in polymicrobial infection. 
Less sensitive in fungal, Acanthamoebic, and viral infections. 
Majority of infections respond to empiric therapy. 
Takes days-weeks for results, depending on the organism. 
Rarely changes clinical judgment. 
Antibiotic sensitivity testing is based on serum concentrations, not corneal. 
Supply costs, laboratory fees. 
DISCUSSION 
Biological Staining 
Staining corneal samples with Gram and Giemsa stains 
for immediate diagnostic information shows variable 
clinical usefulness. Several studies consistently show a 
low yield of bacteria in bacterial keratitis. Sensitivity of 
Gram staining was reported for bacterial keratitis to 
be 36% to 40%, although samples were obtained after 
antibiotic use which may lower bacterial yield [29]. 
Other studies have shown the sensitivity of gram 
staining to be 57% to 67% in similar cases [13, 17, 18]. 
Staining with potassium hydroxide (KOH) and 
calcofluor white are only done when there is clinical 
suspicion of fungi and Acanthamoeba, respectively 
[30], which would be missed with common staining 
methods [23]. 
One study of 3,298 eyes found the sensitivity of KOH 
wet mount to be 99% for the detection of fungi, 100% 
for Nocardia, and 91% for Acanthamoeba, suggesting 
that KOH wet mounts be available and used in all 
clinics treating infective keratitis [23]. A review 
reported that staining methods, while showing high 
specificity, are only able to provide diagnostic value in 
only 27% to 62% of cases of infectious keratitis and 
are thus restricted in utility by insufficient sensitivity 
[30]. Given their variability in sensitivity, staining 
methods alone do not warrant taking corneal samples 
in cases of infectious keratitis or pausing antibiotic 
therapy to increase diagnostic yield.  
Culturing 
Some published guidelines recommend culturing corneal 
ulcers in all cases of suspected infectious keratitis due to 
their potential guidance in cases refractory to empiric 
therapy [3, 12, 31]. Culturing ideally enables clinicians to 
identify pathogens that would not respond to empiric 
therapy (i.e. highly resistant species of bacteria) and 
switch antimicrobial therapy before ulcers become 
refractory and progress in severity (Table 2). However, 
refractivity to medical management is defined as a lack 
of clinical response in 48 hours after starting empiric 
therapy [11], and this may be shorter than the time 
required for culture results to return. For example, 
anaerobic bacteria need to be incubated up to 10 days 
for diagnostic reliability [5], and 25% of fungal cultures 
do not become positive until 2-10 days after inoculation 
[19]. Furthermore, culturing of the eyelid and conjunctiva 
has not been particularly helpful in identifying infectious 
pathogens due to low specificity [32]. 
Other potential benefits of cultures and sensitivity 
studies include potentially minimizing patient exposure 
to antibiotic toxicity, which possibly delays healing of an 
ulcer [33, 34]. However, culture results were used to 
guide therapy in only 4% of nonfungal infectious keratitis 
cases [12]. Moreover, 10% of 82 patients seen by corneal 
specialists and 0% of 75 patients with corneal ulcers seen 
at a general ophthalmology practice needed changes in 
antibiotic regimen due to culture and antibiotic 
sensitivity results [35]. Since culture results do not often 
change clinical decision making, their usefulness for 
preventing medication toxicity remains unclear.  
Cornea specialists have been found to successfully 
identify between bacterial, fungal, amoebic keratitis for 
73% of cases [36] and could distinguish bacterial from 
fungal origin 66% of the time [37]. This leaves 
approximately one-third to one-fourth of cases in which 
culturing may be necessary to guide treatment. 
Moreover, clinicians could predict Gram stain, genus, and 
species in only 46%, 25%, and 10% of cases, respectively 
[37]. Clinicians have shown to more accurately predict 
causal species in P. aeruginosa and Acanthamoeba 
infection due to distinguishing characteristics on clinical 
appearance [36, 38]. These results suggest a need for 
cultures for microbial identification; however, in a study 
of 114 mild to severe ulcers, having culture results did 
not significantly affect outcome [39]. The vast majority 
(up to 94%) of ulcers resolve with empiric antibiotic 
therapy [12]. This supports the idea of a selective 
approach to culturing patients, as the majority of ulcers 
are successfully treated without knowledge of the 
causative organism; however, future research is needed 
to determine which clinical characteristics of ulcers 
indicate the need for culturing.  
Another argument in the importance of culturing 
organisms is one of population health, as gathering this 
information allows us to track which organisms are 
causing infectious keratitis, their antibiotic resistance 
profiles, and important risk factors that may emerge to 
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guide future developments in anti-microbial therapy [40]. 
Along these lines, tailoring antibiotics to avoid the long 
term use of broad-spectrum antibiotics can help reduce 
resistance rates [41]. Previous overuse of systemic 
broad-spectrum antibiotics has resulted in Gram-positive 
(i.e. methicillin-resistant Staphylococcus aureus [MRSA]) 
and Gram-negative bacteria resistant to older ophthalmic 
antibiotics and newer fluoroquinolones used to treat 
infectious keratitis [41, 42]. However, appointed 
academic institutions could gather this epidemiological 
data without the need for general ophthalmologists and 
non-academic cornea specialists to culture each case of 
infectious keratitis. 
Sensitivity and specificity estimates of cultures in the 
diagnosis of infectious keratitis are limited by the fact 
that culturing is currently considered the gold diagnostic 
standard. Many studies in the literature report 
percentages of culture-positive cases of suspected 
infectious keratitis, but the exact proportion of true cases 
of infectious keratitis picked up on cultures is largely 
unknown. For example, in a review of four trials, an 
average of 52% of 735 eyes with ulcerative keratitis were 
positive for bacteria [40]. However, since other microbial 
domains cause ulcerative keratitis, as well as 
noninfectious causes, the sensitivity of culturing bacterial 
isolates can only be speculated without comparing 
culturing to other means of detecting bacteria, such as 
polymerase chain reaction (PCR).  
In a literature review of 20 studies, a median of 50% of 
clinically diagnosed cases of infectious keratitis were 
culture-positive [30]. In cases of infectious keratitis due 
to Acanthamoeba, cultures were positive in only 33%. 
This is contrasted with 100% and 71% sensitivity of in 
vivo confocal microscopy (IVCM) and PCR, respectively 
[28]. In suspected cases of fungal keratitis, culture 
samples have been reported positive 25% to 59% of the 
time [24-27]. Viral cultures for HSV have notoriously poor 
sensitivity. In a study of 48 patients with clinically 
diagnosed HSV keratitis, only 21% showed positive 
cultures [20]. Slit lamp examination with fluorescein is 
often more useful in the diagnosis of viral keratitis. 
However, the diagnosis may not be made until weeks to 
months after initial presentation, when bacterial 
infection can be excluded due to prolonged clinical 
course, final stromal appearance, and anterior chamber 
reaction. It is possible that bacterial superinfection can 
occur on top of viral keratitis. Culturing would be more 
likely to show bacterial growth in this case, and the 
treatment of the bacterial infection would take 
precedence over the viral infection.  
Clearly, the clinical usefulness of microbial cultures in the 
diagnosis of infectious keratitis is limited by its poor 
sensitivity in bacterial cases. Culturing becomes even less 
sensitive in empiric therapy-resistant causes of infectious 
keratitis (i.e. fungus, Acanthamoeba), which are thought 
to warrant culturing in the first place (Table 2). 
Financial Limitations 
Staining and culturing corneal samples could abate 
expensive management of refractory ulcers by 
preventing complications and unnecessary spending on 
medications. On the other hand, the cost of supplies and 
laboratory fees and the lack of technicians trained to 
expertly interpret smear and stain results on-site may 
limit their routine use [15]. Infectious keratitis has been 
reported to have a significant financial burden on 
patients due to costs associated with clinic visits and 
medications and indirectly due to lost wages, glasses 
purchases, and caregiver payments [43]. Patients of 
lower socioeconomic status (SES) are disproportionately 
burdened with a higher incidence of infectious keratitis 
[44, 45], and unnecessary corneal scrapings with 
subsequent laboratory costs compound this financial 
burden. However, low SES and uninsured status are 
independent risk factors for hospitalization from corneal 
ulceration [46], and therefore may actually warrant the 
extra expense of cultures. A cost-benefit analysis has not 
been done to determine if routine sampling would 
decrease healthcare expenditures by preventing the 
progression of infectious keratitis. 
Antibiotic Sensitivity Testing 
Besides smears and cultures, corneal specimens can be 
sent for antibiotic sensitivity testing, which theoretically 
could be used to guide antibiotic therapy. However, 
antibiotic sensitivity testing determines susceptibility of 
bacteria to antibiotics at achievable serum 
concentrations. Thus, because topical ophthalmic 
antibiotics can reach much higher concentrations on the 
cornea, bacteria may respond to treatment for which 
they were designated resistant [12, 39, 47]. Nine out of 
11 patients refractory to empiric therapy should have 
responded to given antibiotics based on their reported 
antibiotic sensitivities. Antibiotic sensitivity testing has 
not been shown to be clinically useful for guiding 
treatment of infectious keratitis [47]. 
Future Alternatives 
Newer technologies are available that can improve our 
diagnostic ability. Ocular samples can also be sent for 
PCR, but this technology is not widely available yet in the 
office setting. PCR has currently been limited to viral 
keratitis, such as herpetic keratitis [30]. PCR assay can 
take 4-8 hours to come to a diagnosis compared to 2-10  
days for positive bacterial and fungal cultures [19]. 
Reports comparing PCR to culturing show improved 
sensitivity and comparable specificities for many 
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different infectious agents, suggesting PCR as another 
alternative to cultures for the diagnosis of keratitis [28, 
30]. In vivo confocal microscopy has been reported with 
high sensitivity in the diagnosis of larger organisms 
causing infectious keratitis, specifically Acanthamoeba 
and filamentous fungi [31, 48].  
CONCLUSION 
When faced with a case of infectious keratitis, 
ophthalmologists must rely on accrued experience and 
clinical acumen to determine whether cultures will help 
guide treatment and improve prognosis. Stains and 
cultures have the potential to guide future therapy for a 
patient should the ulcer resist empiric therapy. If 
conducted promptly, smears and cultures may even 
prevent progression of infectious keratitis and save the 
patient from vision loss and expensive medical bills. 
Furthermore, gathering epidemiological data on 
infectious keratitis could help develop future 
antimicrobial therapy. Despite these, staining methods 
and cultures are especially limited by poor sensitivity in 
microbes that cause treatment failure, often take too 
long to yield diagnostic results, and have not been shown 
to frequently change clinical decision making in the 
community-based setting. Newer technologies, such as 
PCR, may increase diagnostic yield from corneal scrapings 
but are not yet widely available. Currently, there is a 
shortage of well-designed studies evaluating the clinical 
utility and cost-effectiveness of accepted guidelines for 
the diagnosis of infectious keratitis.  
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